Macula Study Group
Head: Priv. Doz. Dr. Stefan Sacu
Scientific Team: Priv. Doz. Dr. Wolf Bühl, Dr. Günther Weigert, Dr. Georgios Mylonas, Dr. Roman Dunavölgyi, Dr. Markus Ritter, Cand med Katharina Eidenberger, Cand med Marin Vujic
Phone: +43 1 40 400 79620
Recent Scientific Projects
• New therapies for exsudative macula diseases
• Management of therapy refractory exsudative macula degeneration
• Pathogenesis of retinal vein occlusions
• Optimizing the local therapy after intravitreal injektions
• Correlation of morphological, angiographic and functonal results in different retinal diseases
• Long term therapeutic effect of intravitreal anti-VEGF injections in different retinal diseases
• Examination of cytokines in the eye in different retinal diseases
• Mutation analysis and genetic mapping in different retinal dystrophies
• Evaluation of new pharmalocigal therapeutic options with electrophysiological methods in macula diseases
• Establishment of genetic therapies for the treatment of hereditary retinal diseases (in cooperation with the Institute of Cellular and Molecular Biology of the University of Pennsylvania, Prof. Jean Bennett)
Scientific Cooperations
• Abteilung für klinische Pharmakologie, Medical University Vienna
• Institut für Humangenetik, Medical University Vienna
• Institut für Physik, Medical University Vienna
• Klinische Abteilung für Hämatologie und Hämostaseologie, Medical University Vienna
• Klinisches Institut für Medizinische und Chemische Labordiagnostik, Medical University Graz
Quick Links
Featured
